Change of Lung Volumes in Chronic Obstructive Pulmonary Disease Patients with Improvement of Airflow Limitation after Treatment

치료 후 기류제한이 호전된 만성폐쇄성폐질환 환자에서 폐용적의 변화

  • Park, Hun Pyo (Department of Medicine, Keimyung University School of Medicine) ;
  • Park, Soon Hyo (Department of Medicine, Keimyung University School of Medicine) ;
  • Lee, Sang Won (Department of Medicine, Keimyung University School of Medicine) ;
  • Seo, Yong Woo (Department of Medicine, Keimyung University School of Medicine) ;
  • Lee, Jeong Eun (Department of Medicine, Keimyung University School of Medicine) ;
  • Seo, Chang Kyun (Department of Medicine, Keimyung University School of Medicine) ;
  • Kwak, Jin Ho (Department of Medicine, Keimyung University School of Medicine) ;
  • Jeon, Young June (Department of Medicine, Keimyung University School of Medicine) ;
  • Lee, Mi Young (Department of Preventive Medicine, Keimyung University School of Medicine) ;
  • Chung, In Sung (Department of Preventive Medicine, Keimyung University School of Medicine) ;
  • Kim, Kyung Chan (Department of Medicine, Daegu Catholic University School of Medicine) ;
  • Choi, Won-Il (Department of Medicine, Keimyung University School of Medicine)
  • 박훈표 (계명대학교 의과대학 내과학교실) ;
  • 박순효 (계명대학교 의과대학 내과학교실) ;
  • 이상원 (계명대학교 의과대학 내과학교실) ;
  • 서용우 (계명대학교 의과대학 내과학교실) ;
  • 이정은 (계명대학교 의과대학 내과학교실) ;
  • 서창균 (계명대학교 의과대학 내과학교실) ;
  • 곽진호 (계명대학교 의과대학 내과학교실) ;
  • 전영준 (계명대학교 의과대학 내과학교실) ;
  • 이미영 (계명대학교 의과대학 예방의학교실) ;
  • 정인성 (계명대학교 의과대학 예방의학교실) ;
  • 김경찬 (대구가톨릭대학교 내과학교실) ;
  • 최원일 (계명대학교 의과대학 내과학교실)
  • Received : 2004.05.25
  • Accepted : 2004.06.15
  • Published : 2004.08.30

Abstract

Background : It is important to predict the exercise capacity and dyspnea, as measurements of lung volume, in patients with COPD. However, lung volume changes in response to an improvement in airflow limitation have not been explored in detail. In the present study, it is hypothesized that lung volume responses might not be accurately predicted by flow responses in patients with moderate to severe airflow limitations. Methods : To evaluate lung volume responses, baseline and follow up, flow and lung volumes were measured in moderate to severe COPD patients. The flow response was defined by an improvement in the $FEV_1$ of more than 12.3%; lung volume changes were analyzed in 17 patients for the flow response. Results : The mean age of the subjects was 66 years; 76% were men. The mean baseline $FEV_1$, $FEV_1$/FVC and RV were 0.98L (44.2% predicted), 47.5% and 4.65 L (241.5%), respectively. The mean follow up duration was 80 days. The mean differences in the $FEV_1$, FVC, TLC and RV were 0.27 L, 0.39 L, -0.69 L and -1.04 L, respectively, during the follow up periods. There was no correlation between the delta $FEV_1$ and delta RV values(r=0.072, p=0.738). Conclusion : To appropriately evaluate the lung function in patients with moderate to severe airflow limitations; serial lung volume measurements would be helpful.

배 경 : 만성폐쇄성폐질환 환자의 운동능력 및 호흡곤란은 폐용적에 크게 영향을 받는다. 그러나 만성폐쇄성폐질환에서 기류의 변화와 이와 관련된 폐용적 변화에 대한 연구는 많지 않다. 본 연구는 기류제한이 호전된 만성폐쇄성폐질환 환자에서 기류제한의 호전과 폐용적 변화의 상관관계를 알아보고자 하였다. 방 법 : 폐용적의 변화를 평가하기위해 중등도 이상의 만성 폐쇄성폐질환 환자를 대상으로 추적 검사에서 $FEV_1$이 기저치에 비해 12.3% 이상 증가한 17명의 환자를 대상으로 기저치와 추적 폐활량 및 폐용적을 비교 분석하였다. 결 과 : 평균 연령은 66세 였고, 76%가 남자였다. 기저치 $FEV_1$은 평균 0.98 L (예측치의 44.2%), $FEV_1$/FVC은 47.5%, 기저치 평균 RV은 4.65 L (예측치의 241.5%) 였다. 추적 폐기능검사는 평균 80일이 지나서 시행하였다. 추적 폐기능 검사의 평균값의 변화는 $FEV_1$ 270 ml, FVC 390 ml 정도 증가한데 비하여 전폐용적은 690 ml 그리고 잔기량은 1,040 ml 감소하였고, 이들 사이에 통계적으로 유의한 상관관계는 관찰되지 않았다. 결 론 : 만성폐쇄성폐질환 환자에서 추적시 폐용적을 포함한 폐기능검사가 치료반응 판정에 도움을 줄 수 있을 것으로 사료된다.

Keywords

References

  1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD scientific commiffee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-76
  2. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:822-6
  3. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278:1355-60
  4. Mitchell RS, Stanford RE, Johnson JM, Silvers GW, Dart G, George MS. The morphologic features of the bronchi, bronchioles, and alveoli in chronic airway obstruction: a clinicopathologic study. Am Rev Respir Dis. 1976;114:137-45
  5. Hale KA, Ewing SL, Gosnell BA, Niewoehner DE. Lung disease in long-term cigarette smokers with and without chronic air-flow obstruction. Am Rev RespirDis.1984;130:716-21
  6. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med.1996;153:1530-5
  7. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:1557-65
  8. Leith DE, Brown R. Human lung volumes and the mechanisms that set them. Eur Respir J. 1999;13: 468-72
  9. Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest. 2002;121:1042-50
  10. Belman MJ, Botnick WC, Shin JW. Inhaled bron chodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pul monary disease. Am J Respir Crit Care Med. 1996; 153:967-75
  11. Hatipoglu U, Laghi F, Tobin MJ. Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 1999;160:1916-21
  12. Sourk RL, Nugent KM. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis. 1983;128:153-7
  13. Dubois AB, Botelho SY, Bedell GN, Marshall R, Comroe JH Jr. A rapid plethy smographic method for measuring thoracic gas volume. J Clin Invest. 1956;35:322-326
  14. Quanjer PH, Tammeling G, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. 1993;6 (Suppl. 16):5-40
  15. Holmes PW, Campbell AH, Barter CE. Acute changes of lung volumes and lung mechanics in asthma and in normal subjects. Thorax. 1978;33:394-400
  16. Cerveri I, Pellegrino R, Dore R, Corsico A, Fulgoni P, van de Woestijne KP, Brusasco V. Mechanisms for isolated volume response to a bronchodilator in patients with COPD. J Appl Physiol. 2000;88:1989-95
  17. Taube C, Lehnigk B, Paasch K, Kirsten DK, Jorres RA, Magnussen H. Factor analysis of changes in dyspnea and lung function parameters after bron chodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:216-20